The decree also establishes a framework for the regulation of veterinary medical products, including vaccines, biological products, and complementary products. It requires establishments to obtain licenses and follow good practices in manufacturing and distribution.
Who should read this
Companies involved in the veterinary medical products industry should review this decree immediately.
Directly affected
Key facts
- Federal Decree by Law No. (21) of 2025
- Issued on 01 Oct 2025
- Effective from 01 Jan 2026
- Regulates veterinary medical products and pharmaceutical establishments
- Establishes a framework for marketing authorization and manufacturing
What this means for you
Veterinary medical product manufacturers and distributors must comply with the new regulations, ensuring quality and safety standards are met.
Directly affected: veterinary medical product manufacturers, distributors, pharmaceutical establishments
Source
UAE Legislation Portal — Finance & Banking (Sector 46)
https://uaelegislation.gov.ae/en/legislations/3942
Original-source date: 2025 · Captured: 2026-05-18T18:15+00:00Z
Show full English translation / verbatim source text
This update is generated from a public regulator publication and reviewed under the firm's automated editorial quality gate. General information only — it does not constitute legal advice. For advice on a specific matter, please contact us. Last updated: 18 May 2026.